Imidazopyridine derivatives as A2B adenosine receptor antagonists
US7855202B2 · kind B2 · utility
12Cited by
6References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2006 |
| Grant date | Dec 21, 2010 |
| Priority date | — |
| Expiry date | Apr 17, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to imidazopyridine derivatives of formula (I):The present disclosure also relates to a method for treating a subject afflicted with a pathological condition or disease susceptible to amelioration by antagonism of the A2B adenosine receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.